RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+16.06%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.94B
AUM Growth
+$2.94B
(+14%)
Cap. Flow
+$60.2M
Cap. Flow
% of AUM
2.04%
Top 10 Holdings %
Top 10 Hldgs %
43.94%
Holding
91
New
27
Increased
20
Reduced
25
Closed
12
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$80M |
| 2 |
uniQure
QURE
|
$61.4M |
| 3 |
Labcorp
LH
|
$51.8M |
| 4 |
Xeris Biopharma Holdings
XERS
|
$45.8M |
| 5 |
MOR
MorphoSys AG American Depositary Shares
MOR
|
$38.5M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$78.7M |
| 2 |
Puma Biotechnology
PBYI
|
$74.6M |
| 3 |
Penumbra
PEN
|
$65.6M |
| 4 |
Regenxbio
RGNX
|
$40.9M |
| 5 |
Abbott
ABT
|
$39.4M |
Sector Composition
| 1 | Healthcare | 93% |
| 2 | Financials | 1.03% |
| 3 | Technology | 0.19% |
| 4 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
26
DELISTED
Cymabay Therapeutics
CBAY
| $39.7M | 1.35% | 2,957,765 +2,200 | +0.1% | +$29.5K |
|
|
MOR
27
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $38.5M | 1.31% | +1,269,800 | New | +$38.5M |
|
28
AnaptysBio
ANAB
$569M
| $36.9M | 1.25% | 519,250 -3,900 | -0.7% | -$277K |
|
|
HSKA
29
DELISTED
Heska Corp
HSKA
| $36.8M | 1.25% | 354,776 +116,330 | +49% | +$12.1M |
|
30
UnitedHealth
UNH
$281B
| $35.1M | 1.19% | 143,020 -2,400 | -2% | -$589K |
|
31
Elevance Health
ELV
$71.8B
| $34.8M | 1.18% | +146,000 | New | +$34.8M |
|
|
CBIO
32
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
| $32.7M | 1.11% | 2,029,347 -252,921 | -11% | -$4.08M |
|
33
iRhythm Technologies
IRTC
$5.46B
| $32.6M | 1.11% | 401,303 -328,571 | -45% | -$26.7M |
|
34
eHealth
EHTH
$118M
| $30.5M | 1.03% | 1,377,895 +47,400 | +4% | +$1.05M |
|
|
OXFD
35
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $28.8M | 0.98% | 2,235,207 -234,480 | -9% | -$3.02M |
|
|
NITE
36
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $28.6M | 0.97% | 1,785,446 +16,500 | +0.9% | +$264K |
|
|
CTLT
37
DELISTED
CATALENT, INC.
CTLT
| $27.7M | 0.94% | +661,850 | New | +$27.7M |
|
|
38
Abbott
ABT
$231B
| $27.4M | 0.93% | 449,300 -646,800 | -59% | -$39.4M |
|
|
EPZM
39
DELISTED
Epizyme, Inc
EPZM
| $27.4M | 0.93% | 2,021,389 +9,400 | +0.5% | +$127K |
|
40
Scholar Rock
SRRK
$3.14B
| $27.3M | 0.93% | +1,750,408 | New | +$27.3M |
|
|
ELGX
41
DELISTED
Endologix Inc
ELGX
| $24.5M | 0.83% | 4,326,389 -1,596,772 | -27% | -$9.04M |
|
42
Teleflex
TFX
$5.59B
| $21.4M | 0.73% | 79,886 -96,700 | -55% | -$25.9M |
|
43
Zoetis
ZTS
$69.3B
| $21.2M | 0.72% | +249,100 | New | +$21.2M |
|
|
CMRX
44
DELISTED
Chimerix, Inc.
CMRX
| $17.1M | 0.58% | 3,589,490 -139,200 | -4% | -$663K |
|
|
SYRS
45
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $16.7M | 0.57% | 1,631,237 -21,003 | -1% | -$214K |
|
|
TCDA
46
DELISTED
Tricida, Inc. Common Stock
TCDA
| $15M | 0.51% | +500,000 | New | +$15M |
|
|
ODT
47
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $13.5M | 0.46% | 610,600 +16,400 | +3% | +$362K |
|
48
Teladoc Health
TDOC
$1.37B
| $13.4M | 0.46% | 231,000 -42,200 | -15% | -$2.45M |
|
|
49
Penumbra
PEN
$10.6B
| $9.97M | 0.34% | 72,170 -474,909 | -87% | -$65.6M |
|
|
JNCE
50
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $9.3M | 0.32% | 1,214,593 +32,200 | +3% | +$247K |
|